• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苔藓抑素1影响P-糖蛋白磷酸化,但不影响多药耐药人乳腺癌细胞的功能。

Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.

作者信息

Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg P M, Bates S E

机构信息

Medicine Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

出版信息

Clin Cancer Res. 1995 Dec;1(12):1581-7.

PMID:9815959
Abstract

The function of P-glycoprotein (Pgp), which confers multidrug resistance by active efflux of drug, is thought to be dependent on phosphorylation. Previous studies have suggested that protein kinase C (PKC) plays an important role in Pgp phosphorylation. We report here the effects of bryostatin 1, a unique PKC activator and inhibitor, on Pgp function in a multidrug-resistant MCF-7 human breast cancer subline which overexpresses PKC-alpha. Bryostatin 1 (100 nM) decreased Pgp phosphorylation after 24 h of treatment. In contrast, it did not affect Pgp function as demonstrated by the accumulation of [3H]vinblastine and rhodamine 123. We compared the effect of bryostatin 1 treatment on PKC-alpha with that of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (200 nM). 12-O-tetradecanoylphorbol-13-acetate caused translocation of PKC-alpha from the cytosol to the cell membrane after a 10-min treatment and its down-regulation after 24 h of treatment. Likewise, bryostatin 1 (100 nM) caused translocation, but only after longer treatment (1 h), and it caused down-regulation of PKC-alpha at 24 h of treatment. Thus, while the MCF-7TH cells overexpress the PKC-alpha isoform, and its down-regulation by bryostatin 1 is associated with decreased Pgp phosphorylation, these alterations do not modulate drug transport. We conclude that, while bryostatin 1 may be useful clinically because of its ability to inhibit PKC, it is not able to reverse Pgp-mediated multidrug resistance.

摘要

P-糖蛋白(Pgp)通过药物的主动外排赋予多药耐药性,其功能被认为依赖于磷酸化。先前的研究表明蛋白激酶C(PKC)在Pgp磷酸化中起重要作用。我们在此报告了苔藓抑素1(一种独特的PKC激活剂和抑制剂)对过表达PKC-α的多药耐药性MCF-7人乳腺癌亚系中Pgp功能的影响。苔藓抑素1(100 nM)处理24小时后可降低Pgp磷酸化。相比之下,如[3H]长春碱和罗丹明123的蓄积所示,它不影响Pgp功能。我们比较了苔藓抑素1处理对PKC-α的影响与佛波酯12-O-十四酰佛波醇-13-乙酸酯(200 nM)的影响。12-O-十四酰佛波醇-13-乙酸酯处理10分钟后导致PKC-α从细胞质转位到细胞膜,处理24小时后导致其下调。同样,苔藓抑素1(100 nM)也导致转位,但仅在更长时间处理(1小时)后出现,并且在处理24小时时导致PKC-α下调。因此,虽然MCF-7TH细胞过表达PKC-α同工型,且苔藓抑素1对其下调与Pgp磷酸化降低相关,但这些改变并未调节药物转运。我们得出结论,虽然苔藓抑素1因其抑制PKC的能力在临床上可能有用,但它不能逆转Pgp介导的多药耐药性。

相似文献

1
Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.苔藓抑素1影响P-糖蛋白磷酸化,但不影响多药耐药人乳腺癌细胞的功能。
Clin Cancer Res. 1995 Dec;1(12):1581-7.
2
Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.苔藓抑素1和佛波酯对人乳腺癌细胞系的不同作用。
Cancer Res. 1992 Mar 1;52(5):1278-83.
3
Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.佛波酯处理后,药物敏感和多药耐药的人KB癌细胞中柔红霉素蓄积减少:蛋白激酶C在减少药物内流中的潜在作用
Oncol Res. 1996;8(6):249-57.
4
Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.苔藓抑素1对人髓系白血病细胞中蛋白激酶C活性及钙敏感亚型表达的调节:与分化及阿糖胞苷诱导凋亡的关系
Exp Cell Res. 1996 Oct 10;228(1):65-75. doi: 10.1006/excr.1996.0300.
5
Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.苔藓抑素1使人类宫颈癌细胞对顺二氯二氨铂(II)敏感化。
Cancer Res. 1992 Jun 1;52(11):3119-24.
6
Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.苔藓抑素1和2对SH-SY5Y人神经母细胞瘤细胞形态和功能分化的影响。
Cancer Res. 1990 Jun 1;50(11):3422-8.
7
Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.苔藓抑素1可诱导过表达蛋白激酶Cα的LNCaP人前列腺癌细胞中细胞外调节蛋白激酶的持续激活及凋亡。
Mol Pharmacol. 2000 Jun;57(6):1224-34.
8
Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.蛋白激酶抑制剂星形孢菌素通过一条不依赖α、β和ζ蛋白激酶C的途径,诱导人神经母细胞瘤SH-SY5Y细胞形成成熟神经元表型。
J Cell Physiol. 1993 May;155(2):301-12. doi: 10.1002/jcp.1041550211.
9
Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.苔藓抑素1在抑制佛波酯诱导的分化的同时,保护小鼠角质形成细胞中的蛋白激酶C-δ不被下调。
Mol Pharmacol. 1994 Nov;46(5):840-50.
10
Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.苔藓抑素1、苔藓抑素2和12-O-十四酰佛波醇-13-乙酸酯对A549人肺癌细胞蛋白激酶C活性影响的比较
Cancer Res. 1989 Jun 15;49(12):3242-5.

引用本文的文献

1
Beyond Competitive Inhibition: Regulation of ABC Transporters by Kinases and Protein-Protein Interactions as Potential Mechanisms of Drug-Drug Interactions.超越竞争性抑制:激酶和蛋白-蛋白相互作用对 ABC 转运蛋白的调节作为药物-药物相互作用的潜在机制。
Drug Metab Dispos. 2018 May;46(5):567-580. doi: 10.1124/dmd.118.080663. Epub 2018 Mar 7.
2
Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.蛋白激酶C介导的药物转运体活性、定位及表达调控
Int J Mol Sci. 2017 Apr 4;18(4):764. doi: 10.3390/ijms18040764.
3
Marine Natural Products as Models to Circumvent Multidrug Resistance.
海洋天然产物作为克服多药耐药性的模型。
Molecules. 2016 Jul 8;21(7):892. doi: 10.3390/molecules21070892.
4
PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.PKCalpha 诱导的胰腺癌耐药与转化生长因子-β1 相关。
J Exp Clin Cancer Res. 2010 Aug 5;29(1):104. doi: 10.1186/1756-9966-29-104.
5
Protein kinases and multidrug resistance.蛋白激酶与多药耐药性。
Cytotechnology. 1998 Sep;27(1-3):203-24. doi: 10.1023/A:1008073006495.
6
A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study.一项关于两种布立他汀-1(NSC339555)给药方案用于晚期恶性黑色素瘤患者的随机II期研究:加拿大国家癌症研究所临床试验组研究
Invest New Drugs. 2002 Nov;20(4):407-12. doi: 10.1023/a:1020694425356.
7
A phase II study of bryostatin 1 in metastatic malignant melanoma.苔藓抑素1用于转移性恶性黑色素瘤的II期研究。
Br J Cancer. 1998 Nov;78(10):1337-41. doi: 10.1038/bjc.1998.680.
8
Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.多基因表达分析揭示了G2期和G3期乳腺癌之间的明显差异,以及蛋白激酶C η与多药耐药基因1、多药耐药相关蛋白和肺耐药相关蛋白基因表达的相关性。
Br J Cancer. 1998;77(1):87-91. doi: 10.1038/bjc.1998.13.
9
Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells.MCF-7/Adr乳腺癌逆转细胞中蛋白激酶C与多药耐药基因表达的协同缺失
Br J Cancer. 1997;75(9):1330-5. doi: 10.1038/bjc.1997.225.
10
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.选择性双吲哚马来酰亚胺蛋白激酶C抑制剂GF 109203X对P-糖蛋白介导的多药耐药性的影响
Br J Cancer. 1996 Sep;74(6):897-905. doi: 10.1038/bjc.1996.454.